News

What the wires are covering — grouped by story, scored for tone

Previous-day view · Wed Nov 4 close. You are previewing the previous trading day. Subscribe to see today live and every other date — Trader is $59/mo. Sign up Sign in

Reading Yesterday's tape

Yesterday

Novo Nordisk Stock Jumped After Earnings — But Its CEO Won't Give 2027 Guidance. Here's What Investors Should Know

The Wegovy maker raised its outlook again and the stock jumped. But its CEO refused to forecast next year, and handed investors six clues instead.

Top story · 4 outlets Moving · NVO +5.0% fool.com Positive 100% NVO +4.95% about 18 hours ago

Novo Nordisk Stock: 2 Reasons for Hope From Wegovy Maker's Earnings · barrons.com · 1 day ago
Novo Nordisk raises 2026 outlook as Wegovy pill beats forecasts · reuters.com · 1 day ago
Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts · reuters.com · 1 day ago

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Wegovy pill uptake and CagriSema trial results shape the growth recovery story.

Top story · 5 outlets Moving · NVO +5.0% fool.com Positive 100% NVO +4.95% about 20 hours ago

Novo Nordisk Q3: Just The Report I Was Waiting For (NYSE:NVO) · seekingalpha.com · 1 day ago
Novo Nordisk A/S 2026 Q3 - Results - Earnings Call Presentation (TSX:NOVO:CA) 2026-11-04 · seekingalpha.com · 1 day ago
Novo shares jump 6% as Wegovy pill sales impress, drugmaker hikes outlook · cnbc.com · 1 day ago
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook · cnbc.com · 1 day ago

Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in Earnings

Top story · 3 outlets Moving · NVO +5.0% barrons.com Negative 100% NVO +4.95% about 24 hours ago

Novo Nordisk Weight-Loss Pill Sales Soar. One Other Earnings Revelation Boosting the Stock. · barrons.com · 1 day ago
Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly · reuters.com · 1 day ago

Novo Surges After Crushing Forecasts On The Back Of Its GLP-1s

The GLP-1 drugs Ozempic and Wegovy put up resounding sales beats.

Top story · 3 outlets Moving · NVO +5.0% investors.com Positive 100% NVO +4.95% 1 day ago

Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs · investors.com · 1 day ago
Novo improves outlook on continued demand for Wegovy pill, Ozempic (NVO:NYSE) · seekingalpha.com · 1 day ago

Novo Nordisk: 3 Key Takeaways for Long-Term Investors

U.S. pricing pressure weighs on Novo Nordisk's growth, but management is counting on the pipeline to offset it over the long haul.

Moving · NVO +5.0% fool.com Negative 86% NVO +4.95% about 13 hours ago

Novo hikes outlook again as it speeds up Wegovy pill rollout

Moving · NVO +5.0% reuters.com Positive 100% NVO +4.95% 1 day ago

Yesterday

2381 stories

Positive 40% Neutral 34% Negative 26%

NVO tone

7d 30d 90d

Today reads warmer than 2 of the last 10 scored days. Click a bar to read that day's stories.

Most covered

24h

SPCX -3.81% 26 stories DDOG -14.42% 23 stories TSLA -3.34% 21 stories DUOL +25.99% 20 stories AMZN +6.12% 19 stories CVS -12.53% 19 stories AMD +1.01% 17 stories NVO +4.95% 17 stories NDAQ +2.55% 16 stories ANET +5.04% 15 stories FIS -23.67% 14 stories GOLD +5.9% 14 stories